View Post

Bird Flu Vaccine Authorized to Save California Condors

In COVID-19, Latest News by Precision Vaccinations

The United States Department of Agriculture's Agricultural Research Service (APHIS) today announced they approved the emergency use of a highly pathogenic avian influenza (HPAI) vaccine candidate to prevent additional deaths of California Condors. 
This vaccine clinical trial will be carried out with the surrogate vultures in North Carolina beginning in May 2023.
As of May 12, 2023, twenty-one Condors have died related to HPAI infections in 2023.
In April 2023, the USDA's Agricultural Research Service began testing several candidate vaccines.

View Post

mRNA Pancreatic Cancer Vaccine Candidate Shows Promising Results

In COVID-19, Latest News by Precision Vaccinations

Messenger RNA (mRNA) vaccines may be the hottest thing in vaccine research. But even before the recent pandemic began, Memorial Sloan Kettering Cancer Center (MSK) researchers had already been testing mRNA vaccine technology with a different purpose — as a treatment for cancer.
Pancreatic cancer surgeon Vinod Balachandran, MD, has been leading the first clinical trial to test mRNA vaccines as a potential therapy for pancreatic cancer.
The vaccines are custom-made for every person.

View Post

Pharmacies Reduced COVID-19 Under-Vaccinations

In COVID-19, Latest News by Precision Vaccinations

With locations near most intersections, recent data show that more than two-thirds of adult COVID-19 vaccinations were administered at pharmacies during the pandemic. 
And a recent study found these pharmacists were very good at enabling their patients to protect themselves from severe COVID-19.
This peer-reviewed study was published by the journal Vaccines on May 11, 2023, and examined trends in primary series and multi-dose completion rates with Moderna’s COVID-19 vaccine administered at retail pharmacies in the U.S.

View Post

Mpox Vax Flops in Chicago

In COVID-19, Latest News by Precision Vaccinations

When the global mpox outbreak began in May 2022, various health agencies quickly authorized a vaccine to be administered based on historical clinical data.
However, those vaccine effectiveness decisions may have been premature compared to new real-world data.
The U.S. Centers for Disease Control and Prevention (CDC) recently confirmed a cluster of mpox cases in greater Chicago, Illinois.
And more than 50% of the new mpox cases in Chicago were in previously vaccinated people. 

View Post

Texas Confirmed Locally-acquired Dengue Case

In COVID-19, Latest News by Precision Vaccinations

While the U.S. Centers for Disease Control and Prevention (CDC) recently confirmed Dengue viruses are a risk in many parts of Central and South America, Mexico, and the Caribbean, the state of Texas could be added to the list.
As of early May 2023, the Texas Department of State Health Services (DSHS) reported its initial locally-acquired Dengue patient.